HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Di Giacomo, C. Articles by Vanella, A. Search for Related Content PubMed PubMed Citation Articles by Di Giacomo, C. Articles by Vanella, A.

---

HEME OXYGENASE

Novel Inhibitors of Neuronal Nitric Oxide Synthase

C. Di Giacomo^*,1, V. Sorrenti^*, L. Salerno, V. Cardile, F. Guerrera, M.A. Siracusa, M. Avitabile^* and A. Vanella^*

^* Department of Biochemistry, Medical Chemistry and Molecular Biology,
Department of Pharmaceutical Sciences,
Department of Physiological Sciences, University of Catania, Catania, Italy

Abstract

Selective inhibitors of neuronal nitric oxide synthase (nNOS), which are devoid of any effect on the endothelial isoform (eNOS), may be required for the treatment of some neurological disorders. In our search for novel nNOS inhibitors, we recently described some 1-[(Aryloxy)ethyl]-1H-imidazoles as interesting molecules for their selectivity for nNOS against eNOS. This work reports a new series of 1-[(Aryloxy)alkyl]-1H-imidazoles in which a longer methylene chain is present between the imidazole and the phenol part of molecule. Some of these molecules were found to be more potent nNOS inhibitors than the parent ethylenic compounds, although this increase in potency resulted in a partial loss of selectivity. The most interesting compound was investigated to establish its mechanism of action and was found to interact with the tetrahydrobiopterin (BH₄) binding site of nNOS, without interference with any other cofactors or substrate binding sites.

Key Words: imidazole derivatives • nNOS • selective inhibitors • BH₄